Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. MRNA

Healthcare  —  Biotechnology
198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
S&P 500 Member
Indexes indicate stock being part of an index
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Moderna, Inc. (MRNA) P/S ratio

As of 25 September 2026, Moderna, Inc. (MRNA) trades at a P/S ratio of 35.5×. Over the past ten years it has ranged from 0.0× (December 2018) to 543× (May 2020); the current reading is higher than 74% of that period. That is above the Biotechnology industry median of 11.5× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 5.9× 19.60%
FY2024 4.9× (21.38%)
FY2023 6.3× 71.42%
FY2022 3.7× (33.93%)
FY2021 5.5× (88.82%)
FY2020 49.6× (54.06%)
FY2019 108× 1,076.69%
FY2018 9.2× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period P/S ratio Change
Jun 2026 12.5× 38.71%
Mar 2026 9.0× 52.83%
Dec 2025 5.9× 30.75%
Sep 2025 4.5× 29.77%
30 more quarters

Against its own ten years

Low 0.0× High 543×
Ten-year median 8.2×
Current reading's percentile 74

P/S ratio against peers

Company P/S ratio
REGN Regeneron Pharmaceuticals, Inc. compare 5.2×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 6.6×
ALNY Alnylam Pharmaceuticals, Inc. compare 7.1×
RPRX Royalty Pharma PLC compare 10.2×
VRTX Vertex Pharmaceuticals Incorporated compare 10.6×
ARGX argenex SE compare 11.2×
INSM Insmed, Inc. compare 22.5×
MRNA Moderna, Inc. 35.5×
RVMD Revolution Medicines, Inc. compare 1,606×
Biotechnology industry median 11.5×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MRNA